World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicExtracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseTM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver DiseaseMedical nutrition therapy in non-alcoholic fatty liver disease--a review of literatureNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsNonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionineBurden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitisZebrafish Models for Dyslipidemia and Atherosclerosis ResearchHepatocellular carcinoma in nonalcoholic fatty liver disease mimicking benign hemangioma: two case reports and literature reviewMetabolic insights from zebrafish genetics, physiology, and chemical biologyPromising therapies for treatment of nonalcoholic steatohepatitis.Cost-utility analysis of nonalcoholic steatohepatitis screening.An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway.Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methodsAssociation between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study.Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targetsTrihalomethane exposure and biomonitoring for the liver injury indicator, alanine aminotransferase, in the United States population (NHANES 1999-2006).Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β.Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model.Nitric oxide in liver diseases.Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetesSystematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han PopulationGlobal publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic reviewAbsence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma.COMPARISON OF HEPATIC PROFILE IN PRE AND POSTOPERATIVE OF BARIATRIC SURGERY: PRIVATE VS PUBLIC NETWORK.Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expressionEthnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic SteatosisAnti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver diseaseRural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD.Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease.Clinical guidelines of non-alcoholic fatty liver disease: A systematic review.Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research.Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis.Identification of Metabolic risk phenotypes predisposing to Non-Alcoholic Fatty Liver Disease in a Pakistani Cohort.
P2860
Q24563381-94EA256D-3372-4FC8-AA0B-C90EB4DB26E6Q26764843-8ADAD416-EAC9-4D1B-BF25-260088060021Q26774883-CEEFC4F8-D1AC-4EB3-B86D-F3C7B369A9D3Q26782452-03707A0B-4DA4-4E3A-813A-CC611E17A850Q26796448-A61F1C56-D152-458A-B845-879157C18605Q26992163-1AF8D996-62EF-4518-B48D-1CC9ED48EA6AQ27000368-A76CD153-F533-430F-91EE-C46DAA0356D7Q28067738-7025B8B0-F01F-48E0-A055-453503AEC2C2Q28069803-5EF4F213-8244-4873-AD38-DEC3D864BBE6Q28077023-9C6C4EE4-CE16-49A4-A10A-224D87231E28Q28084257-86887846-B295-400A-9B9D-8EC800D763BEQ30248578-C7F8AF4D-8569-4AC0-99D5-C9F124688459Q30385602-B8996810-1A95-48C1-98DD-914302BDEAECQ33819857-A4D68F35-F270-4024-9CEF-881F86BE38DDQ33832177-CF7CAC7E-6DD4-4EC0-91E6-B2099E0E6203Q34746071-45695D1B-05A3-4920-A49F-041431D2C0FAQ35527594-88588C5F-AD72-4EE6-99CE-21271F8C7906Q35619340-71F1E782-B643-45A4-94A6-53D99361DDCCQ35629725-06427C31-6553-4564-90FB-83302AB2E0EEQ35668745-904FE208-5525-4538-993B-683C5C5E0EE6Q35711933-C3ED1E14-1688-45B2-AB0C-B6418330F86DQ35744933-3A4E4DA9-B990-4E49-937C-66767BEB588EQ35858018-67C88D1A-4FCF-47FB-8878-F365FF7C5A13Q35890416-6A1C1DB5-7E88-4413-8C25-EFE70696F0F7Q35940869-B262208D-74B9-4D39-BD53-AAC091DA50A1Q36050336-9C935CE9-FAAE-424B-84FC-2650A7F29D76Q36140409-ED35D265-C5A5-4102-9170-4A5D9CDD1699Q36279133-6A098F36-2338-4895-A152-FFBDBB832D11Q36369189-B704401B-9AC7-4A83-AF91-43CE0E07D9C0Q36411927-4DCEAB4F-B438-4CFC-8078-F7425A032861Q36584501-793E436F-B53C-443E-B02B-BD9979C28C82Q36656592-436DD1C4-84E9-4FB3-9745-7943C5EB16CBQ37035153-9DDFE16B-3ED8-481A-85CB-2C59A2E85175Q37218156-8826D726-707D-447D-BF9C-7A356D371DFFQ37246601-EE19ACE8-248E-4347-974C-F7E625C7829AQ37266496-35B6DA5C-1DF9-454D-A7BE-E4BB0364AF16Q37284519-E52D949F-BCA1-46FF-88CC-1CE927BE8F57Q37443840-D14F802D-9E56-436C-A095-16FBB15A7C20Q37554361-8A7D593E-AB62-47A6-9CB3-B5E926944B53Q37723542-2E81C838-5E8B-4913-B3A1-D9BF31E9D8AE
P2860
World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@ast
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@en
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@nl
type
label
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@ast
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@en
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@nl
prefLabel
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@ast
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@en
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@nl
P2093
P50
P1476
World Gastroenterology Organis ...... nonalcoholic steatohepatitis.
@en
P2093
Aamir G Khan
Alan B R Thomson
Douglas R LaBrecque
Frank Anania
Juan F R Ramos
Justus Krabshuis
Khean-Lee Goh
Manuel M Peñaranda
Maribel Lizarzabal
Muhammed Umar
P304
P356
10.1097/MCG.0000000000000116
P577
2014-07-01T00:00:00Z